The modifications incorporated in VCN-01 are; a selective replication depending on pRB pathway deregulation (for tumor selectivity), a retargeting modification RGDK in the fiber shaft binding (for tumor targeting) and the expression of a modified hyaluronidase (to break down the extracellular matrix). This evidence concerns the gene RB1 and neoplasm.